Issue: May 2012
April 05, 2012
1 min read
Save

Antidepressant use ups risk for pregnancy-induced hypertension

Issue: May 2012
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Use of antidepressants during pregnancy appears to increase the risk for pregnancy-induced hypertension beyond the risk that can be attributed to depression or anxiety disorders.

Researchers used data from the Quebec Pregnancy Registry to compare 1,216 women who had been diagnosed with pregnancy-induced hypertension with or without preeclampsia to 12,160 matched controls. None of the women had a history of hypertension before pregnancy.

Anick Bérard, PhD

Anick Bérard

At least one prescription for an antidepressant was filled by 345 women during pregnancy (3.7% cases vs. 2.5% controls). After adjustment for potential confounders, antidepressant use during pregnancy was associated with a 53% increased risk for pregnancy-induced hypertension (OR=1.53; 95% CI, 1.01-2.33).

Stratified analyses revealed that the risk for pregnancy-induced hypertension was associated with use of selective serotonin reuptake inhibitors (OR=1.60; 95% CI, 1.00-2.55) and, more specifically, paroxetine (OR=1.81; 95% CI, 1.02-3.23).

“These results are an early indicator or risk attributable to antidepressant drug treatment above that which may be attributed to depression or anxiety disorders in the absence of drug treatment,” Anick Bérard, PhD, of the Université de Montréal and CHU Sainte Justine Research Center, said in a press release.

“This research adds another piece of evidence and shows the importance of fully assessing the risks and the benefits of antidepressant use during pregnancy for the mother and child,” Bérard said.

Disclosure: Dr. Berard was a consultant in the litigation involving antidepressants.